A Phase 1/2 Randomised, Observer-Blind Study of the Safety, Reactogenicity, and Immunogenicity of 3 SARS-CoV RNA Vaccine Candidates in Adults Previously Vaccinated and Not Previously Vaccinated Against SARS-CoV-2
- Funded by National Medical Research Council Singapore
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Start & end year
N/AFunder
National Medical Research Council SingaporePrincipal Investigator
Jenny LowResearch Location
SingaporeLead Research Institution
SHHQResearch Priority Alignment
N/A
Research Category
Vaccines research, development and implementationResearch Subcategory
Phase 1 clinical trialSpecial Interest Tags
N/AStudy Type
ClinicalClinical Trial Details
Clinical Trial, Phase IBroad Policy Alignment
PendingAge Group
UnspecifiedVulnerable Population
UnspecifiedOccupations of Interest
Unspecified